Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Neoadjuvant Operable Breast Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1586 Carcinoma, Non-Small-Cell Lung 1114 Prostatic Neoplasms 839 Colorectal Neoplasms 701 Multiple Myeloma 621 Leukemia, Myeloid, Acute 599 Neoplasms 566 Lung Neoplasms 564 Neoplasm Metastasis 535 Lymphoma 481 Pancreatic Neoplasms 479 Carcinoma, Hepatocellular 466 Stomach Neoplasms 437 Leukemia 435 Recurrence 422 Melanoma 381 Leukemia, Lymphocytic, Chronic, B-Cell 374 Ovarian Neoplasms 368 Precursor Cell Lymphoblastic Leukemia-Lymphoma 366 Lymphoma, Non-Hodgkin 357 Myelodysplastic Syndromes 352 Squamous Cell Carcinoma of Head and Neck 348 Lymphoma, Large B-Cell, Diffuse 346 Head and Neck Neoplasms 340 Brain Neoplasms 338 Rectal Neoplasms 330 Glioblastoma 329 Carcinoma, Renal Cell 286 Hodgkin Disease 280 Esophageal Neoplasms 279

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡